This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


SARS-CoV-2 virus found to migrate within neurons and infect the brain

SARS-CoV-2 virus found to migrate within neurons and infect the brain
Clinical profile of hamsters infected with SARS-CoV-2 original virus (Wuhan), the recombinant Wuhan/ΔORF7ab or the variants of concern (VoC) Gamma, Delta, and Omicron/BA.1. A, B Body weight variation over four days post-infection. C Lung weight measured at 4 dpi. D, E Clinical score over four days post-infection. The clinical score is based on a cumulative 0–4 scale: ruffled fur; slow movements; apathy; and absence of exploration activity. F Lung weight-to-body weight ratio measured at 4 dpi. AF Horizontal lines indicate median and the interquartile range (n = 8/group). B, C, E, F Kruskal-Wallis test followed by the Dunn’s multiple comparisons test (the adjusted p value is indicated when significant). G, H Olfactory performance measured at 3 days post-infection (dpi). The olfaction test is based on the hidden (buried) food finding test. Curves represent the olfactory performance of animals during the test (G) and bars represent the final results (H) (n = 8/group). Chi-square test for trend (the adjusted p value is indicated when significant). See Supplementary Figs. 1, 2. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-40228-7

The emergence of different variants of SARS-CoV-2 has produced a wide range of clinical profiles and symptoms in patients. For the first time, researchers at the Institut Pasteur and Université Paris Cité have demonstrated, in an animal model, a characteristic common to several SARS-CoV-2 variants: the ability to infect the central nervous system.

The study confirms that SARS-CoV-2 is capable of infecting human neurons in vitro and migrating into axons, the nerve cell projections that carry information. The results were published in the journal Nature Communications.

The associated with SARS-CoV-2 infection have changed with the evolution of the virus and the emergence of new variants. At the start of the COVID-19 pandemic, anosmia was identified as one of the typical symptoms of infection, but it was less frequently associated with infections caused by the omicron/BA.1 variant. Does this variability in symptoms indicate a greater or lesser affinity of SARS-CoV-2 for the nervous system?

In this study, researchers from the Institut Pasteur and Université Paris Cité have demonstrated, in an animal model, that a panel of SARS-CoV-2 variants of interest (the original strain of the virus first detected in Wuhan and the gamma, delta and omicron/BA.1 variants) can enter the central nervous system and remain there during the acute phase of the infection.

The researchers observed that all these variants spread to the central nervous system and infect the , a structure located in the cranial cavity that processes olfactory information before transmitting it to the cortex.

"In this study, we demonstrated that infection of the olfactory bulb is common to all variants and not linked to any particular one, nor to any particular clinical manifestation such as anosmia," explains Guilherme Dias de Melo, first author of the study and researcher in the Institut Pasteur's Lyssavirus, Epidemiology and Neuropathology Unit.

Moreover, the researchers identified a linked to anosmia in the ancestral (Wuhan) virus. When this genetic sequence, which encodes the ORF7ab protein, is deleted or truncated—which is the case in certain variants less likely to produce anosmia—the incidence of olfactory loss in infected animals is lower even though the degree of neuronal infection via the olfactory bulbs remains unchanged.

"This suggests that anosmia and neuronal infection are two unrelated phenomena," says Guilherme Dias de Melo. "If we follow this line of reasoning, it is quite possible that even an asymptomatic—and therefore clinically benign—infection is characterized by the spread of the virus in the ."

The researchers then looked at how SARS-CoV-2 reached the olfactory bulb and observed that neurons appeared to be the ideal route. An in vitro microfluidic cell culture system enabled the researchers to observe human neurons organized in a particular way. The neurons are arranged so as to allow detailed observation of the transport of molecules within the axon.

Using this method, the researchers found that, once inside the neuron, the virus is able to move in both directions along the axon, either in an anterograde direction, i.e. from the cell body to the axon terminals, or in a retrograde direction, from the axons to the cell body.

"The virus seems to effectively exploit the physiological mechanisms of the neuron to move in both directions. The SARS-CoV-2 variants we studied—the ancestral Wuhan variant, gamma, delta and omicron/BA.1—infect neurons in vitro and are capable of moving along axons."

"Through this study, we have characterized the neurotropism of SARS-CoV-2. For all the variants studied, brain infection via the olfactory bulb seems to be a common feature of SARS-CoV-2," concludes Hervé Bourhy, last author of the study and head of the Institut Pasteur's Lyssavirus, Epidemiology and Neuropathology Unit.

"The next step will be to understand, from the , whether the virus is able to persist in the brain beyond the acute phase of infection, and whether the presence of the virus can induce persistent inflammation and the symptoms described in cases of long COVID, such as anxiety, depression and brain fog."

More information: Guilherme Dias de Melo et al, Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants, Nature Communications (2023). DOI: 10.1038/s41467-023-40228-7

Journal information: Nature Communications
Provided by Pasteur Institute
Citation: SARS-CoV-2 virus found to migrate within neurons and infect the brain (2023, October 27) retrieved 24 February 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

COVID-19: Discovery of the mechanisms of short- and long-term anosmia


Feedback to editors